We therefore aimed to develop and validate multivariable clinical diagnostic models that combine clinical features and biomarkers to identify type 1 diabetes (defined by rapid insulin requirement and severe endogenous insulin deficiency) in patients aged between 18 and 50 years at diabetes diagnosis. Here, INS is linked to diabetes mellitus.